Memorial Sloan Kettering Cancer Center MSK Cardio-Oncology Symposium 2024 (Videos + PDFs)
Comprehensive Cardio-Oncology Education for Modern Cancer Care
The MSK Cardio-Oncology Symposium 2024, hosted by Memorial Sloan Kettering Cancer Center, is a premier educational program dedicated to the rapidly evolving field of cardio-oncology. This comprehensive symposium explores the cardiovascular complications of cancer therapies, modern strategies for preventing and managing cardiotoxicity, advances in cardiac imaging, cardiac amyloidosis, survivorship care, and the cardiovascular challenges faced by cancer patients throughout the treatment continuum.
Featuring internationally recognized experts in cardiology, oncology, hematology, radiation oncology, and cardiovascular imaging, this program provides a state-of-the-art, case-based review designed to improve cardiovascular outcomes for cancer patients and survivors.
Format: 60 Videos + 43 PDFs
File Size: 22.3 GB
Date: May 2–3, 2024
Location: Zuckerman Research Center, New York, NY
Specialty: Cardio-Oncology | Cardiology | Oncology
Course Overview
Advances in cancer therapy have dramatically improved survival rates across multiple malignancies. As cancer patients live longer, cardiovascular disease has emerged as one of the leading causes of morbidity and mortality among cancer survivors.
Many contemporary cancer treatments—including anthracyclines, HER2-targeted therapies, immune checkpoint inhibitors, radiation therapy, CAR-T therapy, and stem cell transplantation—can adversely affect cardiovascular health.
The MSK Cardio-Oncology Symposium 2024 provides a multidisciplinary review of current evidence, emerging research, diagnostic approaches, and treatment strategies that help clinicians balance optimal cancer therapy with cardiovascular safety.
Target Audience
This program is designed for:
Physicians
• Cardiologists
• Cardio-Oncology Specialists
• Hematologists
• Medical Oncologists
• Radiation Oncologists
• Internal Medicine Physicians
• Critical Care Physicians
• Palliative Care Physicians
• Family Medicine Physicians
Cancer Specialists
• Bone Marrow Transplant Physicians
• Cellular Therapy Specialists
• Leukemia Specialists
• Lymphoma Specialists
• Solid Tumor Oncologists
Advanced Practice Providers
• Nurse Practitioners
• Physician Assistants
Healthcare Professionals
• Oncology Nurses
• Cardiology Nurses
• Residents and Fellows
Learning Objectives
Upon completion of this activity, participants should be able to:
• Understand cardiovascular toxicities associated with modern cancer therapies
• Apply evidence-based monitoring strategies for cardiotoxicity
• Diagnose and manage treatment-related cardiovascular complications
• Utilize contemporary cardiovascular imaging in cancer patients
• Implement permissive cardiotoxicity strategies when appropriate
• Recognize and manage cardiac amyloidosis
• Optimize long-term cardiovascular care for cancer survivors
• Manage acute cardiovascular emergencies during cancer treatment
Foundations of Cardio-Oncology
The Evolving Field of Cardio-Oncology
Topics Covered
• Cancer Survivorship
• Cardiovascular Risk Assessment
• Prevention Strategies
• Multidisciplinary Care Models
• Contemporary Practice Guidelines
Cancer and Cardiovascular Disease
Areas Covered
• Shared Risk Factors
• Cancer-Associated Cardiovascular Disease
• Competing Causes of Mortality
• Long-Term Outcomes
Cancer Therapy–Related Cardiotoxicity
Anthracycline Cardiotoxicity
Topics Include
• Mechanisms of Injury
• Risk Factors
• Early Detection
• Prevention Strategies
• Long-Term Surveillance
Targeted Cancer Therapies
Areas Covered
• HER2-Directed Therapy
• Tyrosine Kinase Inhibitors
• VEGF Inhibitors
• Novel Molecular Therapies
Immunotherapy and Cellular Therapy
Topics Covered
• Immune Checkpoint Inhibitors
• CAR-T Cell Therapy
• Cytokine Release Syndrome
• Myocarditis
• Cardiovascular Monitoring
Radiation-Associated Heart Disease
Areas Covered
• Coronary Artery Disease
• Valvular Disease
• Pericardial Disease
• Long-Term Surveillance
Cardiac Amyloidosis
Diagnosis and Management
Topics Include
• Transthyretin Amyloidosis (ATTR)
• Light Chain (AL) Amyloidosis
• Diagnostic Imaging
• Biomarkers
• Emerging Treatments
Therapeutic Advances
Areas Covered
• Disease-Modifying Therapies
• Early Detection
• Multidisciplinary Care
Permissive Cardiotoxicity
Balancing Cancer Treatment and Cardiac Risk
Topics Covered
• Clinical Decision-Making
• Risk-Benefit Assessment
• Treatment Continuation Strategies
• Cardiology-Oncology Collaboration
Cardiovascular Imaging in Cardio-Oncology
Modern Imaging Approaches
Topics Include
• Echocardiography
• Global Longitudinal Strain (GLS)
• Cardiac MRI
• Cardiac CT
• Nuclear Imaging
Best Practices
Areas Covered
• Baseline Assessment
• Surveillance Protocols
• Guideline Recommendations
• Imaging Interpretation
Acute Cardiovascular Complications
Cardiac Emergencies During Cancer Therapy
Topics Covered
• Acute Heart Failure
• Arrhythmias
• Myocarditis
• Thromboembolic Disease
• Acute Coronary Syndromes
Critical Care Cardio-Oncology
Areas Covered
• Intensive Care Management
• Hemodynamic Monitoring
• Multisystem Complications
Cancer Survivorship and Long-Term Cardiovascular Health
Late Cardiovascular Effects of Cancer Therapy
Topics Include
• Accelerated Atherosclerosis
• Heart Failure
• Arrhythmias
• Valvular Disease
• Vascular Disease
Adult Survivors of Childhood Cancer
Areas Covered
• Long-Term Surveillance
• Cardiovascular Risk Reduction
• Lifelong Follow-Up Strategies
Thrombosis and Vascular Complications
Cancer-Associated Thrombosis
Topics Covered
• Venous Thromboembolism
• Arterial Thrombosis
• Anticoagulation Strategies
• Risk Stratification
Case-Based Learning
Participants review:
• Anthracycline Cardiotoxicity Cases
• Immunotherapy-Associated Myocarditis
• Cardiac Amyloidosis Evaluations
• Cancer Survivor Cardiovascular Screening
• Acute Cardio-Oncology Emergencies
• Advanced Imaging Interpretation
• Complex Clinical Decision-Making Scenarios
Educational Highlights
World-Class Faculty
Featuring experts from Memorial Sloan Kettering and leading cardio-oncology programs worldwide.
Comprehensive Curriculum
Addresses cardiovascular care throughout the entire cancer continuum.
Multidisciplinary Approach
Integrates cardiology, oncology, hematology, imaging, critical care, and survivorship perspectives.
Evidence-Based Focus
Highlights the latest guidelines, research, and emerging therapies.
Why This Course Stands Out
✔ Comprehensive Cardio-Oncology Training
✔ Modern Cancer Therapy Cardiotoxicity Review
✔ Cardiac Amyloidosis Updates
✔ Advanced Cardiovascular Imaging Applications
✔ Immunotherapy and CAR-T Cardiac Complications
✔ Permissive Cardiotoxicity Strategies
✔ Cancer Survivor Cardiovascular Care
✔ Acute Cardiovascular Emergencies in Oncology
✔ Multidisciplinary Expert Faculty
✔ Case-Based Clinical Learning
✔ Guideline-Based Practice Updates
✔ State-of-the-Art Cardio-Oncology Education
Who Should Take This Course?
Ideal for:
• Cardiologists
• Cardio-Oncology Specialists
• Medical Oncologists
• Hematologists
• Radiation Oncologists
• Internal Medicine Physicians
• Advanced Practice Providers
• Oncology Nurses
• Cardiology Fellows
• Oncology Fellows
Clinical & Educational Value
The Memorial Sloan Kettering Cancer Center MSK Cardio-Oncology Symposium 2024 provides a comprehensive review of the cardiovascular challenges associated with modern cancer care. Participants gain advanced knowledge in prevention, diagnosis, monitoring, and treatment of cardiovascular disease in cancer patients and survivors, helping bridge the gap between oncology and cardiovascular medicine while improving long-term patient outcomes.
Topics:
- 2022 ESC Cardio-Oncology Guidelines- Is There Evidence to Identify Who Is at High Risk..mp4
- 2022 ESC Cardio-Oncology Guidelines- Is There Evidence to Identify Who Is at High Risk..pdf
- 5FU Induced Chest Pain- Diagnostic and Management Algorithm.mp4
- 5FU Induced Chest Pain- Diagnostic and Management Algorithm.pdf
- A Decade in Review- Top Research Studies and Clinical Trials in Cardio-Oncology.mp4
- A Decade in Review- Top Research Studies and Clinical Trials in Cardio-Oncology.pdf
- Amyloidosis and Multiple Myeloma- Contemporary Diagnosis and New Advances in Treatment Q&A.mp4
- Atrial Fibrillation and Cancer- Pathophysiology and Management Algorithm.mp4
- Atrial Fibrillation and Cancer- Pathophysiology and Management Algorithm.pdf
- Best Practices in the Management of Cardiovascular Disease in Patients with Cancer Q&A.mp4
- Breast Cancer- Best Practice Strategies to Optimize Outcomes Q&A.mp4
- Cancer Associated Non-Bacterial Thrombotic Endocarditis- Presentation, Pathophysiology, Management and Future Avenues.mp4
- Cancer Associated Non-Bacterial Thrombotic Endocarditis- Presentation, Pathophysiology, Management and Future Avenues.pdf
- Cancer Survivorship and Prevention Q&A.mp4
- Cancer Therapy-Related Cardiac Dysfunction and Heart Failure- Do the Traditional Paradigms Apply..mp4
- Cancer Therapy-Related Cardiac Dysfunction and Heart Failure- Do the Traditional Paradigms Apply..pdf
- Cancer Therapy-Related HTN- Optimal Strategy to Achieve Effective BP Control.mp4
- Cancer Therapy-Related HTN- Optimal Strategy to Achieve Effective BP Control.pdf
- Cancer-Associated Stroke- Etiology, Detection and Management.mp4
- Cancer-Associated Stroke- Etiology, Detection and Management.pdf
- Cardiac Amyloidosis- Unmasking the Great Masquerader – When to Suspect and How to Diagnose.mp4
- Cardiac Amyloidosis- Unmasking the Great Masquerader – When to Suspect and How to Diagnose.pdf
- Cardio-Oncology- Moving the Field Forward Q&A.mp4
- CardioOnc2024_Brochure.pdf
- Cardiotoxicity Associated with Breast Cancer Treatment- Updates on Screening and Management.mp4
- Cardiotoxicity Associated with Breast Cancer Treatment- Updates on Screening and Management.pdf
- Cardiovascular Challenges During and After Bone Marrow Transplant- How to Mitigate Adverse Cardiac Events and Optimize Cardiovascular Health.mp4
- Cardiovascular Challenges During and After Bone Marrow Transplant- How to Mitigate Adverse Cardiac Events and Optimize Cardiovascular Health.pdf
- Cardiovascular complications Associated with Lung Cancer Treatment- Screening, Diagnosis, and Management.mp4
- Cardiovascular complications Associated with Lung Cancer Treatment- Screening, Diagnosis, and Management.pdf
- Cardiovascular Considerations in Hematologic Malignancies Q&A.mp4
- Cardiovascular Considerations of TKI Therapy in Chronic Leukemias.mp4
- Cardiovascular Considerations of TKI Therapy in Chronic Leukemias.pdf
- Cardiovascular Disease Burden in Patients with Cancer- Where and How Cardio-Oncology Can Make a Difference.mp4
- Cardiovascular Disease Burden in Patients with Cancer- Where and How Cardio-Oncology Can Make a Difference.pdf
- Cardiovascular Toxicity with Immune Checkpoint Inhibitors- Myocarditis and Beyond.mp4
- Cardiovascular Toxicity with Immune Checkpoint Inhibitors- Myocarditis and Beyond.pdf
- CART T Cell Therapy- Navigating a New Frontier and Understanding the Cardiovascular Manifestations.mp4
- CART T Cell Therapy- Navigating a New Frontier and Understanding the Cardiovascular Manifestations.pdf
- CASE PRESENTATION- ICI Myocarditis Cases from Mild to Deadly.mp4
- Common Risk Factors Between Cancer and Cardiovascular Disease.mp4
- Common Risk Factors Between Cancer and Cardiovascular Disease.pdf
- Contemporary Lung Cancer Diagnosis and Treatment- A Primer for the Non-Oncologist.mp4
- Contemporary Lung Cancer Diagnosis and Treatment- A Primer for the Non-Oncologist.pdf
- Contemporary Management of Prostate Cancer- Hormonal Therapy, Radiation, and Surgery – What Factors Influence Treatment Decisions..mp4
- Contemporary Management of Prostate Cancer- Hormonal Therapy, Radiation, and Surgery – What Factors Influence Treatment Decisions..pdf
- Coronary Artery Disease in Cardio-Oncology Q&A.mp4
- Developing a Cancer Survivorship Health Care Model.mp4
- Electrophysiology in Cardio-Oncology Q&A.mp4
- Fundamentals of Antitumor Immunity and Current Applications in Solid Tumor Malignancy.mp4
- Fundamentals of Antitumor Immunity and Current Applications in Solid Tumor Malignancy.pdf
- How I Use Strain and Biomarkers in My Practice.mp4
- How I Use Strain and Biomarkers in My Practice.pdf
- How to Manage Patients with Cardiac Implantable Devices During Radiation MRI.mp4
- How to Manage Patients with Cardiac Implantable Devices During Radiation MRI.pdf
- How to Train in Cardio-Oncology- Cardio-Oncology Fellowship Programs.mp4
- How to Train in Cardio-Oncology- Cardio-Oncology Fellowship Programs.pdf
- IC-OS- Opportunities for Collaboration, Research, and Education.mp4
- IC-OS- Opportunities for Collaboration, Research, and Education.pdf
- Immunotherapy- Evolving Landscape in Diagnosing and Managing Immune Related Cardiotoxicity Q&A.mp4
- Implications of Cardiovascular Disease in Prostate Cancer Therapies- How to mitigate CV Risk During ADT.mp4
- Implications of Cardiovascular Disease in Prostate Cancer Therapies- How to mitigate CV Risk During ADT.pdf
- Late Onset Cardiotoxicity in Adult Survivors of Childhood Cancer- Incidence, Risk Factors, and Individual Cardiovascular Risk Prediction.mp4
- Late Onset Cardiotoxicity in Adult Survivors of Childhood Cancer- Incidence, Risk Factors, and Individual Cardiovascular Risk Prediction.pdf
- Lung Cancer- Advances in Treatment and Their Impact on Cardiovascular Health.mp4
- Managing Patients with TTR Amyloidosis- Progress and Challenges.mp4
- Managing Patients with TTR Amyloidosis- Progress and Challenges.pdf
- Metabolic Issues in Cardio-Oncology- Can We Prevent Cancer by Improving Cardiovascular Risk Factors..mp4
- Metabolic Issues in Cardio-Oncology- Can We Prevent Cancer by Improving Cardiovascular Risk Factors..pdf
- MR Imaging of Cardiac Masses- Clinical Applications and Prognostic Implications.mp4
- MR Imaging of Cardiac Masses- Clinical Applications and Prognostic Implications.pdf
- Multimodality Imaging – Which Test, When, and Why..mp4
- Multimodality Imaging – Which Test, When, and Why..pdf
- Multiple Myeloma and AL amyloidosis- A Primer on Diagnosis and Management.mp4
- Multiple Myeloma and AL amyloidosis- A Primer on Diagnosis and Management.pdf
- Navigating Cardiac Interventions in Patients with Active Cancer- Insights from Evidence and Experience.mp4
- Navigating Cardiac Interventions in Patients with Active Cancer- Insights from Evidence and Experience.pdf
- Optimal Management of Patients with Acute Coronary Syndrome and Advanced Cancer.mp4
- Optimal Management of Patients with Acute Coronary Syndrome and Advanced Cancer.pdf
- Pharmacologic Cardioprotective Strategies to Prevent Cardiotoxicity. What Have We Learned from the Clinical Trials..mp4
- Pharmacologic Cardioprotective Strategies to Prevent Cardiotoxicity. What Have We Learned from the Clinical Trials..pdf
- Prescribing Exercise to Mitigate Cardiovascular Toxicity in Clinical Practice- What are the Opportunities and Barriers..mp4
- Prescribing Exercise to Mitigate Cardiovascular Toxicity in Clinical Practice- What are the Opportunities and Barriers..pdf
- Prevention in Cardio-Oncology Q&A.mp4
- Prostate Cancer and Cardiovascular Disease Q&A.mp4
- Racial and Ethnic Disparities in Cardio-Oncology Care- A Call to Action to Achieve Health Equity.mp4
- Racial and Ethnic Disparities in Cardio-Oncology Care- A Call to Action to Achieve Health Equity.pdf
- Radiation Induced Heart Disease- A Practical Guide to Diagnosis and Management.mp4
- Radiation Induced Heart Disease- A Practical Guide to Diagnosis and Management.pdf
- Radiation Therapy and the Heart Q&A.mp4
- Radiation Therapy- Current and Future Strategies to Minimize Radiation Induced Cardiotoxicity.mp4
- Radiation Therapy- Current and Future Strategies to Minimize Radiation Induced Cardiotoxicity.pdf
- Role of Imaging Markers and Biomarkers in Cardio-Oncology- Strategies for Early Detection of Cardiotoxicity. Q&A.mp4
- Striking the Balancing- Navigating Permissive Cardiotoxicity in Cancer Treatment.mp4
- The Future of Clinical Trials- What I have learned Over 30+ Years as a Trialist.mp4
- The Future of Clinical Trials- What I have learned Over 30+ Years as a Trialist.pdf
- Thrombosis and Hemostasis in Cancer Q&A.mp4
- Understanding Stem Cell Bone Marrow Transplant- When, for Whom, and Why..pdf
- Understanding Stem Cell Bone Marrow Transplant- When, for Whom, and Why.mp4
- Updates in the Current Landscape of Contemporary Breast Cancer Treatment- Immunotherapy, HER2-targeted Therapy, and Antibody Drug Conjugates.mp4
- Updates in the Current Landscape of Contemporary Breast Cancer Treatment- Immunotherapy, HER2-targeted Therapy, and Antibody Drug Conjugates.pdf
- Venous Thromboembolism in Cancer Patients- Risk Assessment, Prevention and Treatment.mp4
- Venous Thromboembolism in Cancer Patients- Risk Assessment, Prevention and Treatment.pdf








